These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10499884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G.
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F.
    J Clin Invest; 1997 Apr 01; 99(7):1585-95. PubMed ID: 9120002
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.
    Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M.
    J Am Soc Nephrol; 2001 Mar 01; 12(3):541-549. PubMed ID: 11181802
    [Abstract] [Full Text] [Related]

  • 10. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM.
    Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, Adu D, Morris PJ, Todd JA, Barnett AH, Boulton AJ, Bain SC.
    Diabetologia; 1996 Sep 01; 39(9):1108-14. PubMed ID: 8877296
    [Abstract] [Full Text] [Related]

  • 11. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
    Tarnow L, Kjeld T, Knudsen E, Major-Pedersen A, Parving HH.
    Diabetologia; 2000 Jun 01; 43(6):794-9. PubMed ID: 10907125
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population.
    Gutiérrez C, Vendrell J, Pastor R, Llor C, Aguilar C, Broch M, Richart C.
    Metabolism; 1997 Aug 01; 46(8):976-80. PubMed ID: 9258285
    [Abstract] [Full Text] [Related]

  • 13. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension.
    Ringel J, Beige J, Kunz R, Distler A, Sharma AM.
    Diabetologia; 1997 Feb 01; 40(2):193-9. PubMed ID: 9049480
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus.
    Ilić V, Ilić M, Soldatović I, Popović S, Magić Z.
    Vojnosanit Pregl; 2014 Jul 01; 71(7):627-33. PubMed ID: 25109108
    [Abstract] [Full Text] [Related]

  • 16. Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.
    Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, Cockram CS.
    Diabetes Care; 1998 Mar 01; 21(3):431-7. PubMed ID: 9540028
    [Abstract] [Full Text] [Related]

  • 17. The relationship between ACE/AGT gene polymorphisms and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes.
    Qiao YC, Wang M, Pan YH, Zhang XX, Tian F, Chen YL, Zhao HL.
    J Renin Angiotensin Aldosterone Syst; 2018 Mar 01; 19(1):1470320317752955. PubMed ID: 29378484
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P, Majkowska L, Safranow K, Adler G, Goracy I.
    Przegl Lek; 2007 Mar 01; 64(3):134-9. PubMed ID: 17941464
    [Abstract] [Full Text] [Related]

  • 19. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY, Szeto CC, Chow KM, Chan JC, Li PK.
    Am J Kidney Dis; 2001 Jul 01; 38(1):9-17. PubMed ID: 11431175
    [Abstract] [Full Text] [Related]

  • 20. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, Khullar M.
    DNA Cell Biol; 2009 Mar 01; 28(3):141-50. PubMed ID: 19108684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.